- Home
- NEUE vs CTOR Comparison
NEUE vs CTOR Comparison
Compare NEUE & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEUE
- CTOR
- Stock Information
- Founded
- NEUE 2015
- CTOR 2021
- Country
- NEUE United States
- CTOR United States
- Employees
- NEUE N/A
- CTOR N/A
- Industry
- NEUE
- CTOR
- Sector
- NEUE
- CTOR
- Exchange
- NEUE NYSE
- CTOR NYSE
- Market Cap
- NEUE 61.3M
- CTOR 63.7M
- IPO Year
- NEUE 2021
- CTOR N/A
- Fundamental
- Price
- NEUE $6.80
- CTOR $2.87
- Analyst Decision
- NEUE Hold
- CTOR Buy
- Analyst Count
- NEUE 1
- CTOR 2
- Target Price
- NEUE $7.00
- CTOR $6.00
- AVG Volume (30 Days)
- NEUE 7.6K
- CTOR 2.7M
- Earning Date
- NEUE 08-06-2025
- CTOR 08-11-2025
- Dividend Yield
- NEUE N/A
- CTOR N/A
- EPS Growth
- NEUE N/A
- CTOR N/A
- EPS
- NEUE N/A
- CTOR N/A
- Revenue
- NEUE $907,349,000.00
- CTOR N/A
- Revenue This Year
- NEUE $33.99
- CTOR N/A
- Revenue Next Year
- NEUE $5.90
- CTOR N/A
- P/E Ratio
- NEUE N/A
- CTOR N/A
- Revenue Growth
- NEUE N/A
- CTOR N/A
- 52 Week Low
- NEUE $3.79
- CTOR $0.55
- 52 Week High
- NEUE $7.66
- CTOR $49.00
- Technical
- Relative Strength Index (RSI)
- NEUE 46.55
- CTOR N/A
- Support Level
- NEUE $6.79
- CTOR N/A
- Resistance Level
- NEUE $6.89
- CTOR N/A
- Average True Range (ATR)
- NEUE 0.07
- CTOR 0.00
- MACD
- NEUE -0.01
- CTOR 0.00
- Stochastic Oscillator
- NEUE 6.67
- CTOR 0.00
About NEUE NEUEHEALTH INC
NeueHealth Inc is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated healthcare. It consists of two reportable segments: NeueCare - it's a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act. NeueSolutions - it's a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers to thrive in performance-based arrangements.
About CTOR CITIUS ONCOLOGY INC
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.